Quick Answer
Yubo International Biotech Ltd reported Net Income Loss of -$1.08 million for the year ending 2025.
- Yubo International Biotech Ltd showed an increase of +39.2% in Net Income Loss from 2024 to 2025.
- This data is from Yubo International Biotech Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2011 to 2025), Yubo International Biotech Ltd's Net Income Loss has declined by 881.1%.
- Historical annual values: Fiscal year 2025: -$1.08 million | Fiscal year 2024: -$1.78 million | Fiscal year 2023: -$1.20 million | Fiscal year 2022: -$1.20 million | Fiscal year 2021: -$1.54 million | Fiscal year 2020: -$711.8 thousand | Fiscal year 2020: -$134.0 thousand | Fiscal year 2019: -$148.0 thousand | Fiscal year 2018: -$144.0 thousand | Fiscal year 2017: -$224.0 thousand | Fiscal year 2016: -$130.0 thousand | Fiscal year 2015: -$116.0 thousand | Fiscal year 2014: -$106.0 thousand | Fiscal year 2013: -$103.0 thousand | Fiscal year 2012: -$84.0 thousand | Fiscal year 2011: -$110.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: